A Study on Application of Adjustable Headrest in Painless Curettage Surgery for Overweight and Obese Patients

A Study on Application of Adjustable Headrest in Painless Curettage Surgery for Overweight and Obese Patients: a Randomized Controlled Trial

The aim of this study is to observe the effect of adjustable headrests on ventilation function in overweight and obese patients through clinical experiments, and to explore the impact on the incidence of hypoxemia during painless curettage in overweight and obese patients.

Participants will be randomly allocated to three groups: the supine head-straight position group(Group A), the supine head-lateral position group(Group B), and the adjustable headrest group(Group C). These three groups of patients underwent painless curettage surgery in the daytime operating room and the occurrence of hypoxemia will be observed.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: NaLi, MD
  • Phone Number: +862763490107
  • Email: lina@hbfy.com

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430000
        • Recruiting
        • Maternal and Child Health Hospital of Hubei Province
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • patients who choose to have painless surgical abortion
  • Body mass index greater than 24
  • the American Society of Anesthesiologists (ASA) physical status ranked I-II
  • competent to provide informed consent

Exclusion Criteria:

  • Abnormal lung function or respiratory system diseases
  • Airway obstruction or respiratory malformation
  • cervical spondylosis
  • psychiatric disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: the adjustable headrest group: placing an adjustable pillows on the head
the adjustable headrest group: placing an adjustable pillows on the patient's head to align the patient's external auditory canal horizontally with the sternum
the adjustable headrest group: placing an adjustable pillows on the patient's head to align the patient's external auditory canal horizontally with the sternum
Active Comparator: the supine head-lateral position group
the supine head-lateral position group: during the perioperative period, keep the patient's head tilted to the left or right
the supine head-lateral position group: during the perioperative period, keep the patient's head tilted to the left or right
Placebo Comparator: the supine head-straight position group
the supine head-straight position group: during the perioperative period, keep the patient's head upright
the supine head-straight position group: during the perioperative period, keep the patient's head upright

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of hypoxemia
Time Frame: 1,2 and 3 minutes after anesthesia induction
Incidence of hypoxemia will be recorded after anesthesia induction
1,2 and 3 minutes after anesthesia induction
Respiratory rate and oxygen saturation
Time Frame: The time of entering the daytime operating room, intraoperative period., 1 minute after the patient wakes up
Respiratory rate and oxygen saturation will be recorded at 4 time points, including the time of entering the daytime operating room(Time 0), 1 minute after anesthesia induction(Time 1), 2 minute after anesthesia induction(Time 2), 3 minute after anesthesia induction(Time 3), 1 minute after the patient wakes up(Time 4)
The time of entering the daytime operating room, intraoperative period., 1 minute after the patient wakes up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate and blood pressure
Time Frame: The time of entering the daytime operating room, intraoperative period, 1 minute after the patient wakes up
heart rate and blood pressure will be recorded at 4 time points, including the time of entering the daytime operating room(Time 0), 1 minute after anesthesia induction(Time 1), 2 minute after anesthesia induction(Time 2), 3 minute after anesthesia induction(Time 3), 1 minute after the patient wakes up(Time 4)
The time of entering the daytime operating room, intraoperative period, 1 minute after the patient wakes up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Na Li NaLi, MD, Maternal and Child Health Hospital of Hubei Province

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2025

Primary Completion (Estimated)

February 22, 2026

Study Completion (Estimated)

September 22, 2026

Study Registration Dates

First Submitted

March 27, 2025

First Submitted That Met QC Criteria

April 8, 2025

First Posted (Actual)

April 15, 2025

Study Record Updates

Last Update Posted (Actual)

April 15, 2025

Last Update Submitted That Met QC Criteria

April 8, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MCHH_010

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obese Patients

Clinical Trials on the adjustable headrest group

Subscribe